Therapeutic management of canine babesiosis
Author(s):
Sandeep and Basavaraj Vadari
Abstract:
The present study was conducted at Department of Veterinary Medicine, Veterinary College Hospital, Hebbal, Bengaluru with an objective of studying the incidence of canine babesiosis by blood smear examination and to compare efficacy of different treatment regimen. The study was conducted for a period of six months from July 2022 to Dec 2022. During this study period incidence rate accounts to 1.55 per cent (298/19,166) by microscopic examination. In the clinical trial, all the four-treatment regimen were found to be effective in treatment of canine babesiosis. But on comparison of all the four treatments, treatment regimen III i.e., {Berenil + triple drug therapy (doxycycline-clindamycin -metronidazole) and Calotropis procera} was found to be more efficacious than other three groups which indicates that inclusion of Calotropis procera as an additive has got a beneficial effect in the treatment of canine babesiosis. As regards to the treatment regimen V where Buparvoquone is replaced by Calotropis procera, the treatment may require to be continued for some more days for complete recovery and restoration of haemto-biochemical parameters to normalcy.
How to cite this article:
Sandeep and Basavaraj Vadari. Therapeutic management of canine babesiosis. The Pharma Innovation Journal. 2023; 12(11S): 571-575.